Both in Pharmaceuticals
Actuate Therapeutics vs Pasithea Therapeutics
Over the past year ACTU returned −89.9% and KTTA returned −31.9%; their daily moves had a correlation of 0.14.
ACTU −89.9% KTTA −31.9%Growth of $1, one year, split-adjusted
| Metric | ACTU | KTTA |
|---|---|---|
| Price | $0.6860 | $0.4900 |
| Market cap | $16.5M | $16.4M |
| Today | −6.82% | +2.08% |
| 1 month | −58.5% | −12.5% |
| 6 months | −70.0% | −31.5% |
| Year to date | −88.8% | −62.0% |
| 1 year | −90.0% | −32.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | $45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 134.6% | 63.3% |
| Short % of float | 11.5% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).